Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
1990-9-4
pubmed:abstractText
The cloned long terminal repeats (LTRs) of mouse intracisternal A-particle (IAP) proviral elements differ in their promoter activity. In this study, the LTR from a recently transposed IAP element (rc-mos) is shown to be a more effective promoter both in vivo and in vitro than the LTR from a randomly cloned genomic element (MIA14). These LTRs differ in nucleotide sequence in certain previously defined protein-binding domains. In particular, the MIA14 LTR contains two domains, designated Enh1 and Enh2, with sequence homology to the SV40 enhancer core motif, while in rc-mos the Enh2 position is occupied by a variant sequence which lacks core homology. EBP-80 is a general enhancer core-binding protein originally isolated by virtue of its affinity for the MIA14 Enh2 sequence (Falzon, M., and Kuff, E.L. (1989) J. Biol. Chem. 264, 21915-21922). We now find by quantitative binding studies, binding competition, and UV cross-linking that EBP-80 from both human and mouse cells binds to the "Enh2" motif of rc-mos more strongly than to the Enh2 of MIA14. In vitro transcription from both LTRs is strongly enhanced by addition of EBP-80 showing that binding is related to function. The rc-mos LTR remains the more effective promoter in the presence of added EBP-80. Reciprocal substitution of the Enh2 domains in the two LTRs by site-directed mutagenesis shows that the rc-mos variant confers a 3-fold increment in in vivo promotor activity. The rc-mos motif or a closely related sequence is found in the cloned LTRs of many expressed and/or recently transposed IAP elements. EBP-80 is identified as a cellular transcription factor whose heightened levels in certain mouse cells might result in preferential expression of IAP elements containing this sequence motif.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
265
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13084-90
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:2165492-Animals, pubmed-meshheading:2165492-Base Sequence, pubmed-meshheading:2165492-Cell Line, pubmed-meshheading:2165492-Cell Nucleus, pubmed-meshheading:2165492-Chloramphenicol O-Acetyltransferase, pubmed-meshheading:2165492-Cloning, Molecular, pubmed-meshheading:2165492-DNA Transposable Elements, pubmed-meshheading:2165492-Genetic Variation, pubmed-meshheading:2165492-HeLa Cells, pubmed-meshheading:2165492-Humans, pubmed-meshheading:2165492-Kinetics, pubmed-meshheading:2165492-Mice, pubmed-meshheading:2165492-Molecular Sequence Data, pubmed-meshheading:2165492-Oligonucleotide Probes, pubmed-meshheading:2165492-Plasmids, pubmed-meshheading:2165492-Promoter Regions, Genetic, pubmed-meshheading:2165492-Proviruses, pubmed-meshheading:2165492-Repetitive Sequences, Nucleic Acid, pubmed-meshheading:2165492-Retroviridae, pubmed-meshheading:2165492-Transcription, Genetic, pubmed-meshheading:2165492-Transcription Factors
pubmed:year
1990
pubmed:articleTitle
A variant binding sequence for transcription factor EBP-80 confers increased promoter activity on a retroviral long terminal repeat.
pubmed:affiliation
Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
pubmed:publicationType
Journal Article